Data as of November 13, 2026
Invokana 300 mg Tablet
CANAGLIFLOZIN
Brand: INVOKANA
Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.
Price per fill
NADAC (acquisition)
$730.27/ fill$19.12 / EA
VA Big4
$567.11/ fill$14.85 / EA
Medicaid FFS
$593.84/ fill
Medicaid MCO
$741.32/ fill
Sources: cms/nadac:price-ladder · va/fss-drug-prices:normalized · cms/sdud
What's in the reimbursement
Ingredient cost (38.2 units/fill)$730.27
Dispensing fee & other (state-fixed, not margin)-$136.43
Total reimbursed per fill$593.84
The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.
Medicaid volume backing this card: 26 fee-for-service states, 30 managed-care states.
Full methodology and source columns: /tools/drug-prices/methodology